MENU
TARA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Protara Therapeutics (TARA) Ownership - Who owns Protara Therapeutics?
Profile
Industry
N/A
Address
345 Park Avenue South
Phone
+1 646 844-0337
Employees
27
Web
http://www.protaratx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
192.88M
P/E Ratio
N/A
Total Cash
81.5M
Projected Growth
N/A
Total Debt
4.74M
Revenue
N/A
Risk (Beta)
2.09
Dividend Yield
N/A
Total Cash/Share
2.37
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TARA
Capitalization
193M
P/E Ratio
N/A
Risk (Beta)
2.09
Dividend Yield
N/A
Total Cash
81.5M
Total Cash/Share
2.37
Total Debt
4.74M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
81.8M
P/B Ratio
2.36
Cash Flow
N/A
Earnings
-2.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
21K
Current Ratio
9.85
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-45.53M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-46.07
Shares Held By Institutions
24.6M
Shares Outstanding - Current
34.3M
Total Liabilities
12.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
199.717
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage company, which engages in developing treatments for rare and specialty diseases with significant unmet needs.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 646 844-0337
Employees
27
Web
http://www.protaratx.com